June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Post-operative outcomes after blepharoplasty in patients with glucocorticoid use within 1 year prior to surgery: A TriNetX Analysis
Author Affiliations & Notes
  • William Fredrick Foos
    Ophthalmology, The George Washington University, Washington, District of Columbia, United States
    Ophthalmology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Haig Pakhchanian
    Ophthalmology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Rahul Raiker
    Ophthalmology, West Virginia University School of Medicine, Morgantown, West Virginia, United States
  • Julia Weiner
    Ophthalmology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Janice Maliakkal
    Ophthalmology, The George Washington University, Washington, District of Columbia, United States
    Ophthalmology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Masumi Asahi
    Ophthalmology, The George Washington University, Washington, District of Columbia, United States
    Ophthalmology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Craig Geist
    Ophthalmology, The George Washington University, Washington, District of Columbia, United States
    Ophthalmology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Footnotes
    Commercial Relationships   William Foos None; Haig Pakhchanian None; Rahul Raiker None; Julia Weiner None; Janice Maliakkal None; Masumi Asahi None; Craig Geist None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 605 – A0306. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William Fredrick Foos, Haig Pakhchanian, Rahul Raiker, Julia Weiner, Janice Maliakkal, Masumi Asahi, Craig Geist; Post-operative outcomes after blepharoplasty in patients with glucocorticoid use within 1 year prior to surgery: A TriNetX Analysis. Invest. Ophthalmol. Vis. Sci. 2022;63(7):605 – A0306.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare post-operative outcomes up to 1 year in patients after blepharoplasty with and without glucocorticoid use within 1 year prior to surgery.

Methods : A retrospective cohort study was performed using TriNetX (Cambridge, MA, USA): a federated electronic health record database comprised of US healthcare organizations. Patients with upper or lower eyelid blepharoplasty were identified by CPT code and stratified into two cohorts based on glucocorticoid use 1 year prior to surgery. Glucocorticoids included cortisone, prednisone, prednisolone, methylprednisolone, dexamethasone, betamethasone, and hydrocortisone. 1:1 propensity score matching separated two cohorts while controlling for baseline characteristic and comorbidities: age, BMI, gender, primary hypertension, diabetes mellitus, chronic lower respiratory disease, nicotine dependence, heart failure, and alcohol related disorders. Patients with ocular comorbidities were screened out. Primary post-operative outcomes included dry eye syndrome, lagophthalmos, conjunctival edema, dacryoadenitis, orbital and periorbital cellulitis, strabismus, diplopia, orbital hemorrhage, and acute conjunctivitis. 1-year relative risk of post-operative outcomes were compared between the groups; those with a p-value less than 0.05 being statistically significant.

Results : 17,804 patients were included in the analysis with 8,902 patients in each of the blepharoplasty with and without glucocorticoid use cohorts. The cohort receiving glucocorticoids in the past year had a statistically significant increased risk of post-operative dry eye syndrome (RR, 1.25; 95% CI, 1.16-1.36), lagophthalmos (RR, 1.55; 95% CI, 1.13-2.13), and conjunctival edema (RR, 3.9; 95% CI, 1.95-7.81). No significant difference in risk was attributable to either cohort regarding dacryoadenitis, orbital and periorbital cellulitis, strabismus, diplopia, orbital hemorrhage, and acute conjunctivitis.

Conclusions : Pre-surgical glucocorticoid use up to one year may impact post-operative course following blepharoplasty. Patients receiving glucocorticoids up to one year prior were more likely to develop post-operative dry eye syndrome, lagophthalmos, and conjunctival edema. Appropriate patients should be counselled on such risk both before and after blepharoplasty.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×